Posted by admin / Under Pharmaceutical Marketing
One of the most powerful lobbies, the pharmaceutical drugs lobby, when it supports those running for public office there is one politico they treasure the most: USA Senate Majority head, Harry Reid, (D/NV). Also this USA Senator is the most targeted by the GOP for defeat come this November, as Sharon Angle is Senator Reid’s challenger. But the pharmaceutical drugs lobby is pouring support to Sen. Reid, via a group, which is really a political action committee or a PAC set up by the pharmaceutical drug lobby called “Nevada Families”.
Published on Wednesday 8th of September 2010 08:19:38 AM
continue reading
Posted by admin / Under Pharmaceutical Marketing
www.LibertyJuice.com This particular article disgusted and infuriated me. Dr. John Holdren, Obama’s Science Czar, told those gathered at an AAAS (American Association for the Advancement of Science) meeting that, “America can’t expect to be number one in everything indefinitely.” Then he went on to say that it wasn’t “purely bad that other countries were beginning to make gains on us.” This mindset comes straight out of Loserville and is an embarrassing representation of America’s unique qualities and principles that have consistently made us the most incredible nation in the world. We are historically a nation that knows no limits or...
Published on Wednesday 8th of September 2010 08:19:38 AM
continue reading
Posted by admin / Under Pharmaceutical Marketing
From Tim Carney’s article in the Washington Examiner, Dems tap drug maker millions for PhRMA-friendly bill: Of all the single-industry lobbies in Washington, the largest is the Pharmaceutical Researchers and Manufacturers of America. PhRMA spent $26.2 million on lobbying last year — that’s nearly three times as much as the insurance lobby, America’s Health Insurance Plans, which spent $8.9 million. If you include individual companies’ lobbying, pharmaceuticals blow away the competition, beating all other industries by 50 percent, according to data at the Center for Responsive Politics. Given this Big Pharma clout, it’s unsurprising that the bill Obama’s whipping for...
Published on Wednesday 8th of September 2010 08:19:38 AM
continue reading
Posted by admin / Under Pharmaceutical Marketing
For days now, the health care legislation in the Senate has been stalled. Democrats are divided over a proposed amendment that would let consumers buy pharmaceuticals from abroad. During the presidential campaign, Obama promised to allow such purchases. But earlier this year he announced his opposition in return for pharmaceutical companies promising to spend at least $150 million, and possibly as much as $200 million, to push his health care legislation. President Obama obviously faces a dilemma: either he keeps the campaign promise he made to voters or he keep his later promise to drug companies. Passing the proposed drug...
Published on Wednesday 8th of September 2010 08:19:38 AM
continue reading
Posted by admin / Under Pharmaceutical Marketing
WASHINGTON – The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators. A report due out Monday from the Government Accountability Office also shows that the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such information is more than a decade overdue. (excerpted)
Published on Wednesday 8th of September 2010 08:19:38 AM
continue reading
This Day In History
St. Augustine: the oldest permanent European settlement in the US was founded (1565)
Share this!